SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

Total Voting Rights

29 Feb 2024 08:33

RNS Number : 9548E
Pod Point Group Holdings PLC
29 February 2024
 

29 February 2024

 

Pod Point Group Holdings plc

(the "Company" or "Pod Point")

 

Total Voting Rights and Capital

 

This announcement is made in accordance with Disclosure Guidelines and Transparency Rule 5.6.1 and Article 15 of the Transparency Directive.

 

During the month of February 500,000 Ordinary Shares of £0.001 each ('Ordinary Shares') were allotted to the Pod Point Employee Benefit Trust ('EBT') for the satisfaction of employee share awards. This allotment was satisfied via the Company's block listing arrangement. At 29 February 2024, the total number of Ordinary Shares held by the EBT is 114,280 representing approximately 0.07% of the Company's total voting rights.

 

The Company's issued capital as at 29 February 2024 is 155,200,118 Ordinary Shares. No Ordinary Shares are held in Treasury and all shares have equal voting rights

 

The total number of voting rights in the Company is 155,200,118 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidelines and Transparency Rules.

 

 

Anita Guernari

Company Secretary

 

 

 

 

Enquiries

Teneo(Public relations advisor to Pod Point)

+44 207 353 4200

85fs.podpoint@teneo.com

Mark Burgess, Matt Low, Arthur Rogers

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAPANADALEEA
Date   Source Headline
27th Sep 20224:36 pmRNSPrice Monitoring Extension
2nd Sep 20227:00 amRNSExercise of Options and Issue of New Shares
16th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
30th Jun 20227:00 amRNSCFO Designate Appointment
10th Jun 20223:00 pmRNSSecond Manufacturer Contract
8th Jun 20226:30 pmRNSBlock listing Interim Review
27th May 20224:36 pmRNSPrice Monitoring Extension
9th May 20225:45 pmRNSPublication of Annual Financial Report (updated)
9th May 20224:43 pmRNSPublication of Annual Financial Report
4th May 20222:28 pmRNSDirector Declaration
11th Apr 202212:05 pmRNSNew Contract Win
14th Mar 20224:30 pmRNSDirector/PDMR Shareholding
11th Mar 20225:25 pmRNSDirector Declaration
21st Feb 20229:00 amRNSEstablishment of new ESG Committee
18th Feb 20227:00 amRNSPreliminary Unaudited Results for FY2021
6th Jan 20227:00 amRNSTrading Update and Notice of Results
4th Jan 202211:00 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSDirector Declaration
20th Dec 20214:00 pmRNSAppointment of Joint Corporate Brokers
3rd Dec 20216:33 pmRNSExercise of Over-allotment Option
3rd Dec 20214:57 pmRNSPost-Stabilisation Period Announcement
3rd Dec 20212:15 pmRNSBlock Listing Application
1st Dec 202110:06 amRNSTotal Voting Rights
25th Nov 20214:13 pmRNSNew Contract Win
16th Nov 202111:57 amRNSHolding(s) in Company - Replacement
12th Nov 20217:00 amRNSMid-stabilisation Period Announcement
11th Nov 20214:38 pmRNSHolding(s) in Company
9th Nov 20217:21 amRNSAdmission to Trading on the London Stock Exchange
4th Nov 20211:51 pmRNSApproval and Publication of Prospectus
4th Nov 20217:00 amRNSPre-Stabilisation Period Notice
4th Nov 20217:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.